Dec 6, 2022
In this interview, Clyde W. Yancy MD, MSc, MACC, FAHA, MACP and Alison L. Bailey MD FACC, discuss the Top Takeaways from 2022: Heart Failure. Dr. Yancy discusses trials including DELIVER, TRANSFORM-HF, DCP, BRIGhtn, and the ACC/AHA/HFSA Guidelines.
Nov 29, 2022
Earlier detection of people at risk of HF would enable cardioprotection to be initiated earlier and damage avoided. Current imaging tools (eg. ejection fraction) are not sensitive enough to identify early disease. While GLS has been shown to predict outcomes, this study shows that its use improves the predictive power...
Nov 15, 2022
In an effort to limit unnecessary testing and increase diagnostic yield, current major guideline recommendations recommend a risk-based strategy with deferred testing in low-risk patients, catheterization in high risk patients, and selective noninvasive testing for those at intermediate risk. To date, no...
Nov 8, 2022
Thiazides are recommended first line agents for the treatment of hypertension. They have been demonstrated to lower cardiovascular disease. Which thiazide to choose has been a long-standing issue.
In this interview, Areef Ishani MD, MS and W. Douglas Weaver MD, MACC discuss AHA Late-Breaker: DCP – Chlorthalidone...
Nov 1, 2022
Ultrasound can make it easier for cardiologists to do procedures including angioplasty or stenting when femoral artery is used.
In this interview, Sanjit Jolly MD, MSc and Matt Cavender MD MPH, FACC, with Sun Moon Kim MD FSCAI, FACC, discuss Routine Ultrasound for Vascular Access.
Subscribe on Apple Podcasts |